SCOPUS 정보 검색 플랫폼

Volumn 34, Issue 4, 2007, Pages 264-266

Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1α, 25-dihydroxy-22-oxacalcitriol) in 17 patients [2]

(2) Imagawa, Ichiro b Suzuki, Hiroyuki a,b

a School of Medicine ^* (Japan)

b NIHON UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; LIQUID NITROGEN;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CRYOTHERAPY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; OINTMENT; PAIN; TOPICAL TREATMENT; VERRUCA VULGARIS; VIRUS INFECTION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CALCITRIOL; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; SKIN NEOPLASMS; TREATMENT OUTCOME; WARTS;

EID: 33847662037 PISSN: 03852407 EISSN: 13468138 Source Type: Journal
DOI: 10.1111/j.1346-8138.2007.00266.x Document Type: Letter

Times cited : (34)

References (11)

1
- 0035134469
- Guidelines for the management of cutaneous warts
- Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4-11.
- (2001) Br J Dermatol , vol.144 , pp. 4-11
- Sterling, J.C.¹ Handfield-Jones, S.² Hudson, P.M.³

2
- 0037206296
- Local treatments for cutaneous warts: Systematic review
- Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. Br Med J 2002; 325: 461-464.
- (2002) Br Med J , vol.325 , pp. 461-464
- Gibbs, S.¹ Harvey, I.² Sterling, J.³ Stark, R.⁴

3
- 3843068573
- Successful treatment of therapy-resistant plantar verrucae vulgaris with systemic interferon-beta
- Allam J-P, Hagemann T, Bieber T, Novak N. Successful treatment of therapy-resistant plantar verrucae vulgaris with systemic interferon-beta. J Dermatol 2004; 31: 582-583.
- (2004) J Dermatol , vol.31 , pp. 582-583
- Allam, J.-P.¹ Hagemann, T.² Bieber, T.³ Novak, N.⁴

4
- 1542611388
- 3 derivatives for recalcitrant warts in three immunocompromised patients
- 3 derivatives for recalcitrant warts in three immunocompromised patients. Br J Dermatol 2004; 150: 374-376.
- (2004) Br J Dermatol , vol.150 , pp. 374-376
- Egawa, K.¹ Ono, T.²

5
- 0032811171
- Topical maxacalcitol for treatment of psoriasis vulgaris: A placebo-controlled, double-blind, dose-finding study with active comparator
- Barker JNWN, Ashton RE, Marks R, Harris RI, Berth-Jones J. Topical maxacalcitol for treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol 1999; 142: 274-278.
- (1999) Br J Dermatol , vol.142 , pp. 274-278
- Barker, J.N.W.N.¹ Ashton, R.E.² Marks, R.³ Harris, R.I.⁴ Berth-Jones, J.⁵

6
- 0036754018
- Nonpsoriatic uses of calcipotriol
- Gupta AK, Browne M, Bluhm R. Nonpsoriatic uses of calcipotriol. J Cuta Med Surg 2002: 6: 442-448.
- (2002) J Cuta Med Surg , vol.6 , pp. 442-448
- Gupta, A.K.¹ Browne, M.² Bluhm, R.³

7
- 0029075736
- Efficacy, tolerability, and safety of calcipotriol onintment in disorders of keratinization
- Kragballe K, Steijlen PM, Ibsen HH et al. Efficacy, tolerability, and safety of calcipotriol onintment in disorders of keratinization. Arch Dermatol 1995: 131: 556-560.
- (1995) Arch Dermatol , vol.131 , pp. 556-560
- Kragballe, K.¹ Steijlen, P.M.² Ibsen, H.H.³

8
- 0037420518
- Psoriasis
- Lebwohl M. Psoriasis. Lancet 2003; 361: 1197-1204.
- (2003) Lancet , vol.361 , pp. 1197-1204
- Lebwohl, M.¹

9
- 0031885312
- 3 (tacacitol)
- 3 (tacacitol). Br J Dermatol 1998: 138: 63-70.
- (1998) Br J Dermatol , vol.138 , pp. 63-70
- Ogino, F.M.¹ Sato, Y.² Ohta, H.³

10
- 0035723630
- L inpsoriasis
- L inpsoriasis. Arch Dermatol Res 2002; 293: 620-625.
- (2002) Arch Dermatol Res , vol.293 , pp. 620-625
- Fukuya, Y.¹ Higaki, M.² Higaki, Y.³ Kawashima, M.⁴

11
- 0000002163
- Treatment of vitiligo with topical calcipotriol
- Ameen M, Chu AC. Treatment of vitiligo with topical calcipotriol. Br J Dermatol 1999; 141: 75.
- (1999) Br J Dermatol , vol.141 , pp. 75
- Ameen, M.¹ Chu, A.C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.